Effect of Anakinra on Insulin Sensitivity in Type 1 Diabetes Mellitus
Status:
Unknown status
Trial end date:
2011-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to test whether anakinra is able to reduce insulin resistance.
This will be tested in overweighted type I diabetes mellitus patients, which have no residual
beta-cell function. By using this patient group, all positive effects on glycemic control
should be the consequence of improved insulin sensitivity.
Phase:
Phase 2
Details
Lead Sponsor:
Radboud University
Treatments:
Insulin Insulin, Globin Zinc Interleukin 1 Receptor Antagonist Protein